New antiviral agents
- Cite this article as:
- Abdel-Haq, N., Chearskul, P., Al-Tatari, H. et al. Indian J Pediatr (2006) 73: 313. doi:10.1007/BF02825826
- 153 Views
During the last three decades, a better understanding of viral replication and disease states caused by viral infections have led to the development of newer antiviral agents with enhanced activity and better tolerability. This review focuses on newer systemic and topical antiviral agents that are used in treatment of herpes viruses including herpes simplex type-1 (HSV-1) and type-2 (HSV-2), varicella-zoster virus (VZV) and cytomegalovirus CMV) as well as the human papilloma virus (HPV). Included in this article are the agents famiclovir, penciclovir, valganciclovir, imiquimod, docosanole and brivudin.